ARTIFICIAL PANCREAS WITH CLOSED-LOOP CONTROL FOR TYPE 1 DIABETES: DESIGN, IMPLEMENTATION, AND EVALUATION

Abstract

A closed-loop controller of insulin supply, often known as an artificial pancreas, is used to treat type 1 diabetes. This research presents the status of closed-loop control systems and anticipated future developments while discussing the difficulties of automated glucose management using fuzzy model predictive Controller. By limiting or preventing short- and long-term impacts, these solutions lessen the daily strain of managing diabetes. This paper investigates the current literature on artificial pancreas and suggests a strategy to enhance its regulation. Contrarily, a closed loop system can deliver the proper dose and timing of insulin and glucose. The artificial pancreas' algorithm entails monitoring a patient's blood glucose levels using a glucose sensor before sending a signal to an insulin pump to alter basal insulin dosage in accordance with the desired level of insulin the patient requires. The noninvasive glucose sensor prototype's results point to a promising future for NIR technology in biomedicine, particularly in optical spectroscopy for continuous, real-time glucose monitoring. The outcomes of the non-invasive glucose sensor prototype show that NIR technology has promising applications in biomedicine, particularly in optical spectroscopy for continuous, real-time glucose monitoring.